“Our findings show that radiotherapy is still highly effective in significantly improving local control and disease-free survival in combination with anti-hormones, compared to anti-hormones alone,” said Gerd Fastner, MD, during a presentation at the European Society for Radiotherapy and Oncology (ESTRO) 38 conference in Milan, Italy.